rs34096980

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 1P and 9B. PP3BP4_StrongBP6BS2

The NM_002863.5(PYGL):​c.611A>G​(p.Tyr204Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00299 in 1,613,930 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0024 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0031 ( 13 hom. )

Consequence

PYGL
NM_002863.5 missense

Scores

7
8
3

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:7

Conservation

PhyloP100: 6.28

Publications

9 publications found
Variant links:
Genes affected
PYGL (HGNC:9725): (glycogen phosphorylase L) This gene encodes a homodimeric protein that catalyses the cleavage of alpha-1,4-glucosidic bonds to release glucose-1-phosphate from liver glycogen stores. This protein switches from inactive phosphorylase B to active phosphorylase A by phosphorylation of serine residue 15. Activity of this enzyme is further regulated by multiple allosteric effectors and hormonal controls. Humans have three glycogen phosphorylase genes that encode distinct isozymes that are primarily expressed in liver, brain and muscle, respectively. The liver isozyme serves the glycemic demands of the body in general while the brain and muscle isozymes supply just those tissues. In glycogen storage disease type VI, also known as Hers disease, mutations in liver glycogen phosphorylase inhibit the conversion of glycogen to glucose and results in moderate hypoglycemia, mild ketosis, growth retardation and hepatomegaly. Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Feb 2011]
PYGL Gene-Disease associations (from GenCC):
  • glycogen storage disease VI
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 7: BayesDel_noAF, Cadd, Eigen, MutationAssessor, PROVEAN, REVEL, REVEL [when AlphaMissense, max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.059922606).
BP6
Variant 14-50924018-T-C is Benign according to our data. Variant chr14-50924018-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 313331.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002863.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PYGL
NM_002863.5
MANE Select
c.611A>Gp.Tyr204Cys
missense
Exon 5 of 20NP_002854.3
PYGL
NM_001163940.2
c.509A>Gp.Tyr170Cys
missense
Exon 4 of 19NP_001157412.1P06737-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PYGL
ENST00000216392.8
TSL:1 MANE Select
c.611A>Gp.Tyr204Cys
missense
Exon 5 of 20ENSP00000216392.7P06737-1
PYGL
ENST00000532462.5
TSL:1
c.611A>Gp.Tyr204Cys
missense
Exon 5 of 20ENSP00000431657.1E9PK47
PYGL
ENST00000530336.2
TSL:1
n.678A>G
non_coding_transcript_exon
Exon 5 of 5

Frequencies

GnomAD3 genomes
AF:
0.00238
AC:
362
AN:
152216
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000868
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00353
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00396
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00319
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00273
AC:
687
AN:
251472
AF XY:
0.00274
show subpopulations
Gnomad AFR exome
AF:
0.00117
Gnomad AMR exome
AF:
0.00283
Gnomad ASJ exome
AF:
0.00109
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00337
Gnomad NFE exome
AF:
0.00400
Gnomad OTH exome
AF:
0.00391
GnomAD4 exome
AF:
0.00305
AC:
4461
AN:
1461596
Hom.:
13
Cov.:
30
AF XY:
0.00292
AC XY:
2121
AN XY:
727118
show subpopulations
African (AFR)
AF:
0.000866
AC:
29
AN:
33474
American (AMR)
AF:
0.00295
AC:
132
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00142
AC:
37
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39690
South Asian (SAS)
AF:
0.000162
AC:
14
AN:
86254
European-Finnish (FIN)
AF:
0.00373
AC:
199
AN:
53418
Middle Eastern (MID)
AF:
0.00208
AC:
12
AN:
5766
European-Non Finnish (NFE)
AF:
0.00351
AC:
3905
AN:
1111766
Other (OTH)
AF:
0.00220
AC:
133
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
250
500
751
1001
1251
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
140
280
420
560
700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00238
AC:
363
AN:
152334
Hom.:
3
Cov.:
32
AF XY:
0.00235
AC XY:
175
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.000866
AC:
36
AN:
41578
American (AMR)
AF:
0.00353
AC:
54
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4830
European-Finnish (FIN)
AF:
0.00396
AC:
42
AN:
10618
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00320
AC:
218
AN:
68032
Other (OTH)
AF:
0.00237
AC:
5
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
21
42
62
83
104
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00314
Hom.:
4
Bravo
AF:
0.00226
TwinsUK
AF:
0.00297
AC:
11
ALSPAC
AF:
0.00415
AC:
16
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00349
AC:
30
ExAC
AF:
0.00315
AC:
382
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00376
EpiControl
AF:
0.00391

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
Glycogen storage disease, type VI (3)
-
1
2
not provided (3)
-
-
1
not specified (1)
-
-
1
PYGL-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
BayesDel_addAF
Uncertain
0.12
D
BayesDel_noAF
Pathogenic
0.40
CADD
Pathogenic
29
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.77
D
Eigen
Pathogenic
0.89
Eigen_PC
Pathogenic
0.86
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Uncertain
0.95
D
M_CAP
Uncertain
0.27
D
MetaRNN
Benign
0.060
T
MetaSVM
Pathogenic
1.0
D
MutationAssessor
Pathogenic
3.5
M
PhyloP100
6.3
PrimateAI
Uncertain
0.65
T
PROVEAN
Pathogenic
-7.9
D
REVEL
Pathogenic
0.79
Sift
Uncertain
0.025
D
Sift4G
Benign
0.11
T
Polyphen
1.0
D
Vest4
0.88
MVP
1.0
MPC
0.60
ClinPred
0.062
T
GERP RS
6.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.7
Varity_R
0.83
gMVP
0.89
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34096980; hg19: chr14-51390736; API